VolitionRx Limited Proceeds from Long-Term Debt Issued
VolitionRx Limited (VNRX) reported Proceeds from Long-Term Debt Issued of $962.72 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2026-08-13
- VolitionRx Limited proceeds from issuance of long-term debt for the quarter ending 2026-06-30 was $0.00.
- VolitionRx Limited proceeds from issuance of long-term debt for the quarter ending 2026-03-31 was $962.72K, a 38.69% decline year-over-year.
- VolitionRx Limited proceeds from issuance of long-term debt for the quarter ending 2025-12-31 was $410.00K, a 33.23% decline year-over-year.
- VolitionRx Limited proceeds from issuance of long-term debt for the quarter ending 2025-09-30 was $0.00.
- VolitionRx Limited proceeds from issuance of long-term debt for fiscal 2025 was $1.98M, a 44.70% increase from fiscal 2024.
- VolitionRx Limited proceeds from issuance of long-term debt for fiscal 2024 was $1.37M, a 26.22% decline from fiscal 2023.
- VolitionRx Limited proceeds from issuance of long-term debt for fiscal 2023 was $1.85M, a 21.78% increase from fiscal 2022.
- VolitionRx Limited proceeds from issuance of long-term debt for fiscal 2022 was $1.52M.
| Period end | Proceeds from Issuance of Long-term Debt 3 month | Proceeds from Issuance of Long-term Debt 6 month | Proceeds from Issuance of Long-term Debt 9 month | Proceeds from Issuance of Long-term Debt 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $962.72K 10-Q · filed 2026-08-13 | $1.37M derived: sum of 3 quarters · filed 2026-08-13 | $1.37M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $962.72K 10-Q · filed 2026-05-14 | $1.37M derived: sum of 2 quarters · filed 2026-05-14 | $1.37M derived: sum of 3 quarters · filed 2026-05-14 | $1.37M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $410.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $410.00K derived: sum of 2 quarters · filed 2026-03-31 | $410.00K derived: sum of 3 quarters · filed 2026-08-13 | $1.98M 10-K · filed 2026-03-31 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $0.00 derived: sum of 2 quarters · filed 2026-08-13 | $1.57M 10-Q · filed 2025-11-13 | $2.18M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $1.57M 10-Q · filed 2026-08-13 | $2.18M derived: sum of 3 quarters · filed 2026-08-13 | $2.18M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $1.57M 10-Q · filed 2026-05-14 | $2.18M derived: sum of 2 quarters · filed 2026-05-14 | $2.18M derived: sum of 3 quarters · filed 2026-05-14 | $2.94M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $614.04K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $614.04K derived: sum of 2 quarters · filed 2026-03-31 | $1.37M derived: sum of 3 quarters · filed 2026-03-31 | $1.37M 10-K · filed 2026-03-31 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $754.46K derived: sum of 2 quarters · filed 2025-11-13 | $754.46K 10-Q · filed 2025-11-13 | $2.39M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $754.46K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $754.46K 10-Q · filed 2025-08-14 | $2.39M derived: sum of 3 quarters · filed 2025-08-14 | $2.39M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $0.00 10-Q · filed 2025-08-14 | $1.64M derived: sum of 2 quarters · filed 2025-08-14 | $1.64M derived: sum of 3 quarters · filed 2025-08-14 | |
| 2023-12-31 | $1.64M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $1.64M derived: sum of 2 quarters · filed 2025-03-31 | $1.85M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $216.91K 10-Q · filed 2024-11-14 | ||
| 2023-06-30 | $216.91K 10-Q · filed 2024-08-14 | |||
| 2022-12-31 | $1.52M 10-K · filed 2024-03-25 | |||
| 2019-12-31 | $838.04K 10-K · filed 2020-02-20 | |||
| 2019-06-30 | $282.51K 10-Q · filed 2019-08-12 | |||
| 2018-12-31 | $1.16M 10-K · filed 2020-02-20 | |||
| 2018-06-30 | $875.65K 10-Q · filed 2019-08-12 | |||
| 2017-12-31 | $1.20M 10-K · filed 2019-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |